尼皮卡斯塔特:一种多功能治疗剂 - 药理学活动和临床前景
Rafał Jas1, Malgorzata Milczarek2, Wojciech Kamysz3
1Maria Sklodowska-Curie Medical Academy in Warsaw, Solidarnosci 12, 03-411, Warsaw, Poland.
European journal of pharmacology
|October 16, 2025
概括
尼皮卡斯塔特 (NEP) 是一种选择性多巴胺β-基酶 (DBH) 抑制剂,通过调节神经递质,显示出治疗物质使用障碍的潜力. 它的机制可能有助于减少可卡因复发,并为其他疾病提供治疗可能性.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 尼皮卡斯塔特 (NEP) 是一种选择性的多巴胺β-基酶 (DBH) 抑制剂,比dissulfiram具有更大的选择性.
- 抑制DBH通过影响多巴胺转化来降低诺亚上腺素生物合成,从而影响关键的大脑功能.
- 由于多巴胺的中心作用,NEP的机制与物质使用障碍,特别是可卡因成有关.
研究的目的:
- 为了提供Nepicastat (NEP) 的全面概述.
- 突出NEP多样化的药理学作用和新兴的治疗潜力.
- 探索NEP对各种疾病的重用可能性.
主要方法:
- 对Nepicastat (NEP) 现有研究的文献综述.
- 分析NEP的作用机制,包括抑制多巴胺β-基酶 (DBH).
- 对NEP治疗效果的临床前和临床证据的评估.
主要成果:
- NEP可以选择性地抑制DBH,影响诺亚上腺素和多巴胺水平.
- 有证据表明,NEP可能会减少可卡因的奖励效应,并减轻复发风险.
- NEP的潜力超越了对神经退行性,心血管和瘤疾病的成.
结论:
- 尼皮卡斯塔特 (NEP) 显示出显著的治疗潜力,特别是在物质使用障碍中.
- 国家药物计划的作用机制和广泛适用性要求对药物重用进行进一步调查.
- 进一步的研究至关重要,以充分阐明NEP在各种治疗领域的有效性和安全性.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
457
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
457
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
01:21Pharmacodynamics: Overview and Principles
2.8K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.8K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
436
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
436
01:24Principles of Drug Action
8.1K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
8.1K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928